TMCnet News
Frost & Sullivan Lauds Gentag for Its RFID-based Sensing System for Patient Monitoring and Other Applications(Wireless News Via Thomson Dialog NewsEdge) Based on its recent analysis of the radio frequency (RF) applied medical systems market, Frost & Sullivan said that it is recognizing Gentag with its 2008 North American Award for Technology Innovation. This Award highlights Gentag's development of radio frequency identification (RFID)-based sensor networks. The sensing system uses RF waves to transmit medical sensing data remotely. Gentag has patented the concept of using a cell phone as a universal reader for disposable wireless sensors. The effective combination of cell phone-sensor reader technology with a disposable RFID sensing platform has led to a variety of medical diagnostic applications that provide consumers, physicians, and various industries with easy and instant access to vital information over established wireless networks, the Internet, and client-specific databases. "The company has successfully caused speciation of a technology for sensing threats into one for sensing and monitoring medical ailments, offering a new product for personalized homecare," says Frost & Sullivan Research Analyst Abhishek Dutta. "The monitoring system can operate on a cost effective but daily basis at regular intervals thus meeting the requirement of an inexpensive and end-user friendly product in this market." The RFID reader technology used here by Gentag is a multiprotocol 13.56 MHz RFID chip that has the capability to operate either under Near Field Communication (NFC) or ISO 15693 protocols. The cell phone technology the company has developed, integrates in a single, low-cost device, the various sensor features required for simultaneous detection capabilities of biological, chemical and radiological threats, regardless of location throughout the world. The device can also act as a predicting sensor for other health threats such as food allergies or asthma. This technology can be used to perform basic patient identification and to monitor drug interactions continuously. The aim is to facilitate noninvasive diagnostics through any type of sensing or measurement that can be performed over skin -- and be disposable. "At present, Gentag has patented the use of this technology in a range of different medical applications such as temperature/fever, glucose/diabetes, drug delivery, pain management, skin infections, cardiac and UV," notes Dutta. "Through strategic partnerships, Gentag's technology can find further future applications in random identification of counterfeit items in a plethora of consumer markets." The company is currently testing its technology on quad-band phones, and the results demonstrate that it works effectively on a global scale. In addition, Gentag's technology covers RFID immunoassays for on-the-spot diagnostics using cell phones. In recognition of the novel technical capabilities, Frost & Sullivan presents the 2008 Technology Innovation Award to Gentag. ((Comments on this story may be sent to [email protected])) ((Distributed on behalf of 10Meters via M2 Communications Ltd - http://www.m2.com)) ((10Meters - http://www.10meters.com)) Copyright ? 2008 Wireless News |